Treatment

Written by Phillip George · Last updated: August 30, 2026

Why timing changes the outcome

Tick-borne infections are treatable, and for most of them the single strongest predictor of a good outcome is how early treatment starts. That is clearest with Rocky Mountain spotted fever: the CDC states that doxycycline is most effective at preventing severe complications if it is started within the first five days of illness, and that treatment should be based on clinical suspicion rather than delayed for laboratory confirmation (CDC, Clinical Care of Rocky Mountain Spotted Fever). A 20-year review of 500 hospitalised children in Sonora, Mexico found that treatment starting more than five days after symptom onset was significantly associated with death (Emerging Infectious Diseases, 2026).

Timing matters before illness begins as well. Transmission is not instantaneous for every pathogen. The CDC states that in most cases a tick must be attached more than 24 hours before the Lyme disease bacterium can be transmitted (CDC, How Lyme Disease Spreads). Other pathogens move faster: a CDC review of experimental transmission studies found Powassan virus transmitted within 15 minutes of attachment, and both Anaplasma phagocytophilum and Borrelia miyamotoi within the first 24 hours (Eisen, Ticks and Tick-borne Diseases, 2018). Prompt, correct removal is therefore part of the clinical picture, not separate from it — see our step-by-step guide to removing an attached tick safely.

Bull's-eye rash - early Lyme disease symptom
Image: Wikimedia Commons (CDC, Public Domain)

What published guidance says, infection by infection

Different tick-borne infections are caused by bacteria, protozoa and viruses, and they are not interchangeable. The summaries below reflect the named guidelines as published. They are not a substitute for a clinician's judgement about an individual patient, and the guidelines themselves say so.

Lyme disease

The reference standard in North America is the 2020 clinical practice guideline from the Infectious Diseases Society of America, the American Academy of Neurology and the American College of Rheumatology. For the early rash, erythema migrans, it recommends oral doxycycline, amoxicillin or cefuroxime axetil, and specifies a 10-day course of doxycycline or a 14-day course of amoxicillin or cefuroxime axetil rather than longer courses. Azithromycin is named as the preferred second-line agent for patients who can take neither doxycycline nor a beta-lactam.

Later manifestations are handled differently. For acute neurological involvement of the peripheral nervous system the guideline recommends intravenous ceftriaxone, cefotaxime, penicillin G or oral doxycycline for 14 to 21 days. For Lyme carditis it suggests 14 to 21 days of total therapy, with oral antibiotics for outpatients. For Lyme arthritis it recommends 28 days of oral therapy. The differences are deliberate, which is why a diagnosis of "Lyme disease" on its own does not imply a single treatment.

Deer tick (Ixodes scapularis) - Lyme disease vector
Image: Wikimedia Commons (CDC, Public Domain)

Rocky Mountain spotted fever and other spotted fever rickettsioses

The CDC names doxycycline the treatment of choice for RMSF and all other tick-borne rickettsial diseases, recommended for presumptive treatment in patients of all ages including children under eight and pregnant patients, and states that using antibiotics other than doxycycline is associated with a higher risk of fatal outcomes. The recommended course runs at least three days after fever subsides and until there is evidence of clinical improvement, with a minimum total course of five to seven days (CDC clinical care guidance). The CDC also notes that rash appears in roughly 90% of cases but usually not until two to four days after fever begins, and that fewer than 60% of patients recall a tick bite — which is why waiting for a rash is treated as a clinical error rather than caution (CDC RMSF clinical pocket card).

Anaplasmosis

Doxycycline is again the drug of choice. The CDC recommends 10 to 14 days for suspected anaplasmosis specifically to provide an appropriate length of therapy for possible concurrent Borrelia infection, since the same blacklegged tick transmits both (CDC, Clinical Care of Anaplasmosis). Fever generally subsides within 24 to 48 hours of starting doxycycline; the CDC notes that a lack of response suggests the illness may not be anaplasmosis at all.

Ehrlichiosis

Ehrlichiosis follows the shorter rickettsial pattern rather than the anaplasmosis one. The CDC recommends doxycycline for at least five to seven days and until 72 hours after fever subsides with evidence of clinical improvement (CDC, Clinical Care of Ehrlichiosis).

Babesiosis

Babesiosis is a parasitic infection of red blood cells, so antibacterial regimens do not apply. The 2020 IDSA babesiosis guideline recommends atovaquone plus azithromycin as the preferred combination, with clindamycin plus quinine as the alternative, for 7 to 10 days in immunocompetent patients and often longer when the patient is immunocompromised. The guideline also describes exchange transfusion as an option for selected patients with severe disease. The CDC adds that most asymptomatic patients do not require treatment (CDC, Clinical Care of Babesiosis).

Powassan virus disease

There is no antiviral treatment and no vaccine. The CDC states that clinical management of Powassan virus disease is supportive, and that patients with encephalitis need close monitoring for raised intracranial pressure, seizures and loss of airway protection (CDC, Treatment and Prevention of Powassan Virus Disease). Antibiotics do not treat viral infections, which is one reason species identification and an accurate clinical picture matter. Our overview of tick-borne disease symptoms in humans and how they progress sets out what each illness tends to look like.

Post-exposure prophylaxis: what it is and what it is not

Post-exposure prophylaxis, usually shortened to PEP, means giving an antibiotic after a bite to a person who is not ill, in the hope of preventing an infection that has not yet declared itself. For tick bites it is a narrow intervention with specific entry criteria, not a routine response to finding a tick.

The 2020 IDSA, AAN and ACR guideline recommends prophylaxis only within 72 hours of removing an identified high-risk tick bite, and not for bites that are equivocal risk or low risk. It defines a high-risk bite by three criteria that must all be met: the bite was from an identified Ixodes vector species, it occurred in a highly endemic area, and the tick was attached for 36 hours or more. Where a bite cannot be classified as high-risk with a high level of certainty, the guideline recommends a wait-and-watch approach. For bites that do meet all three criteria, the recommended regimen in all age groups is a single oral dose of doxycycline given within 72 hours of removal, in preference to observation.

Two limits are worth stating plainly. Prophylaxis in this guideline is directed at Lyme disease only; the guideline offers no equivalent recommendation for preventing anaplasmosis, babesiosis, ehrlichiosis or spotted fever after a bite. And a single dose is not treatment. If symptoms develop afterwards, that is a reason to seek care, not a reason to assume the dose failed.

Where jurisdictions have gone further

Some health authorities now apply the high-risk framework to whole regions. The North Carolina Division of Public Health recommends Lyme disease post-exposure prophylaxis for people residing in or travelling to ten counties — Buncombe, Madison, Yancey, Mitchell, Avery, Watauga, Ashe, Alleghany, Surry and Stokes — selected because they have a high incidence of Lyme disease, defined as at least 16 cases per 100,000 residents, or sit geographically between two high-incidence counties (NCDHHS annual tickborne clinician memo, 22 July 2026). The state memo reports that as of 2025, 33 North Carolina counties have established Ixodes scapularis populations, and that county-level Lyme incidence more than doubled from 2024 to 2025 in Watauga, Yancey, Ashe and Alleghany.

Buncombe County's public health guidance sets out the same conditions in plain language for residents: PEP with a single dose of doxycycline should be considered when the attached tick is identified as a blacklegged tick, is estimated to have been attached more than 36 hours based on engorgement or known exposure time, treatment starts within 72 hours of removal, and the bite occurred where Lyme disease is common. Its published answers are equally direct about when PEP does not apply — an unattached tick, a tick that is not a blacklegged tick, an unengorged tick, or a removal more than 72 hours ago (Buncombe County Communicable Disease). This is a good example of guidance tightening around local surveillance data rather than around patient anxiety, and it is why the answer to "should I get antibiotics after this bite?" legitimately differs between a county in western North Carolina and a county where blacklegged ticks are not established.

What testing can and cannot tell you

Engorged tick specimen for testing
Image: Wikimedia Commons (CC BY 2.0)

Most Lyme disease testing does not look for the bacterium. It looks for the antibodies your immune system makes against it, which takes time. The CDC states that serologic assays may be falsely negative during the first four to six weeks after infection, and that FDA-cleared assays have good sensitivity once four to six weeks have passed (CDC, Clinical Testing and Diagnosis for Lyme Disease). A negative result drawn a few days after a bite therefore tells you very little.

CDC laboratory reporting guidance builds that limitation into the result itself: negative results may occur in patients infected within the previous 14 days, and where recent infection is suspected, repeat testing on a new sample collected 7 to 14 days later is recommended (CDC standard two-tier testing interpretation).

The reverse problem also exists. Once antibody titres rise they stay elevated for months to years, so a positive test cannot be used to judge whether treatment worked or whether an infection has cleared. The CDC also notes that positive IgM results should be disregarded if the patient has been ill for more than 30 days, and that patients treated early may be less likely to seroconvert at all.

Because of this window, the 2020 IDSA, AAN and ACR guideline recommends clinical diagnosis rather than laboratory testing for patients with potential exposure in an endemic area who have one or more skin lesions compatible with erythema migrans. It also recommends against testing asymptomatic patients following an Ixodes bite, on the grounds that the result cannot be interpreted usefully.

Testing the tick is a different question

Submitting the tick and testing the tick are not the same thing. The IDSA guideline recommends submitting a removed tick for species identification, because species and attachment duration feed directly into the high-risk criteria above. It recommends against testing a removed Ixodes tick for Borrelia burgdorferi, noting that the presence or absence of the bacterium in the tick does not reliably predict clinical infection.

The CDC is equally direct about commercial tick testing: results should not be used for treatment decisions, a positive result does not mean you were infected, a negative result can create false reassurance because a different unnoticed tick may have been infected, and symptoms will usually appear before results return (CDC, What to Do After a Tick Bite). Tick testing still has real value as surveillance — it tells public health agencies what is circulating locally — but it answers a question about the tick, not about the person.

When to seek care

Published guidance treats the following as reasons to be seen rather than to wait, particularly during tick season or after time in tick habitat:

• An expanding rash at or near a bite site, especially one compatible with erythema migrans
• Fever, severe headache, muscle aches or profound fatigue, with or without a remembered bite
• Facial weakness, neck stiffness, confusion, or shooting or radiating nerve pain
• Palpitations, light-headedness, fainting, breathlessness or chest pain
• Joint swelling, particularly of a single large joint such as the knee
• Persistent fever while already taking antibiotics for Lyme disease, which the IDSA guideline flags as a prompt to consider co-infection with Anaplasma phagocytophilum or Babesia microti

Buncombe County's guidance makes an additional point that generalises well: seek care for a bullseye rash or an unexplained fever during tick season even without a known bite. Nymphal ticks are roughly poppy-seed sized, and a large share of patients never recall being bitten.

Bull's-eye rash - seek medical attention
Image: Wikimedia Commons (CDC, Public Domain)

Symptoms that persist after treatment

Some people feel unwell for a long time after finishing a recommended course. The 2020 IDSA, AAN and ACR guideline addresses this directly: for patients with persistent or recurring nonspecific symptoms such as fatigue, pain or cognitive impairment after recommended treatment, but who lack objective evidence of reinfection or treatment failure, it recommends against additional antibiotic therapy. It defines the objective signs that would indicate persistent infection or treatment failure as findings such as arthritis, meningitis or neuropathy. For arthritis that has not resolved after both an oral and an intravenous course, the guideline suggests referral to a rheumatologist rather than further antibiotics, and states that therapy beyond eight weeks is not expected to add benefit in that situation.

This is a genuinely contested area, and the guideline recommendation is about antibiotics specifically rather than about whether persistent symptoms are real. Ongoing symptoms deserve clinical assessment, including consideration of alternative diagnoses and of co-infection. Our page on the tick-borne diseases found in North America and what causes each one covers the range of infections a clinician may be weighing up.

FAQ

Next best actions

Disclaimer

This page is educational and is not a substitute for professional medical advice, diagnosis or treatment. It describes what named clinical guidelines recommend to clinicians; it does not tell you what to do about your own bite, symptoms or medication. Always seek the advice of a physician or other qualified health provider with any question about a medical condition, and never disregard or delay professional advice because of something you read here.